logo

GOSS

Gossamer Bio·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

GOSS fundamentals

Gossamer Bio (GOSS) released its earnings on Aug 5, 2025: revenue was 11.49M (YoY -88.01%), beat estimates; EPS was -0.17 (YoY -177.27%), beat estimates.
Revenue / YoY
11.49M
-88.01%
EPS / YoY
-0.17
-177.27%
Report date
Aug 5, 2025
EPS
Revenue

Revenue & Expenses

GOSS has released its 2025 Q3 earnings report, with revenue of 13.29M, reflecting a YoY change of 40.23%, and net profit of -48.22M, showing a YoY change of -56.55%. The Sankey diagram below clearly presents GOSS's revenue sources and cost distribution.

Key Indicators

Gossamer Bio (GOSS) key financial stats and ratios, covering profitability, financial health, and leverage.
Gossamer Bio (GOSS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Gossamer Bio (GOSS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Gossamer Bio (GOSS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Gossamer Bio (GOSS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Gossamer Bio (GOSS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield